Literature DB >> 12433488

Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site.

Tasneem Islam1, Melissa Butler, Sulthan A Sikkander, Toshihiko Toida, Robert J Linhardt.   

Abstract

Porcine mucosal heparin was fragmented into low-molecular-weight (LMW) heparin by treatment of periodate-oxidized heparin with sodium hydroxide, followed by reduction with sodium borohydride and acid hydrolysis. Gradient polyacrylamide gel electrophoresis analysis showed a mixture of heparin fragments with an average size of eight disaccharide units. 1D 1H NMR showed two-thirds of the N-acetyl groups were lost on periodate cleavage, suggesting cleavage had occurred at the glucopyranosyluronic acid (GlcpA) and idopyranosyluronic acid (IdopA) residues located within and adjacent to the antithrombin III (ATIII) binding site. The N-acetyl glucopyranose (GlcpNAc) residue was lost on workup. The GlcpA residue, within the ATIII binding site, is on the non-reducing side of the N-sulfo, 3, 6-O-sulfo glycopyranosylamine (GlcpNS3S6S) residue. Thus, periodate cleaved heparin should be enriched in GlcpNS3S6S residues. Two-dimensional correlation spectroscopy (2D COSY) confirmed that LMW heparin prepared through periodate cleavage contained GlcpNS3S6S at its non-reducing end. As expected, this LMW heparin also showed reduced ATIII mediated anti-factor IIa and anti-factor Xa activities. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433488     DOI: 10.1016/s0008-6215(02)00229-x

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  20 in total

1.  Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.

Authors:  Anna Alekseeva; Benito Casu; Giuseppe Cassinelli; Marco Guerrini; Giangiacomo Torri; Annamaria Naggi
Journal:  Anal Bioanal Chem       Date:  2013-11-20       Impact factor: 4.142

2.  NMR methods to monitor the enzymatic depolymerization of heparin.

Authors:  John F K Limtiaco; Szabolcs Beni; Christopher J Jones; Derek J Langeslay; Cynthia K Larive
Journal:  Anal Bioanal Chem       Date:  2010-09-04       Impact factor: 4.142

3.  Glycosaminoglycan Compositional Analysis of Relevant Tissues in Zika Virus Pathogenesis and in Vitro Evaluation of Heparin as an Antiviral against Zika Virus Infection.

Authors:  So Young Kim; Cheri A Koetzner; Anne F Payne; Gregory J Nierode; Yanlei Yu; Rufeng Wang; Evan Barr; Jonathan S Dordick; Laura D Kramer; Fuming Zhang; Robert J Linhardt
Journal:  Biochemistry       Date:  2019-02-13       Impact factor: 3.162

4.  Susceptibility of enoxaparin reducing end amino sugars to periodate oxidation.

Authors:  Anna Alekseeva; Stefano Elli; Cesare Cosentino; Giangiacomo Torri; Annamaria Naggi
Journal:  Carbohydr Res       Date:  2014-09-10       Impact factor: 2.104

5.  Increase in the growth inhibition of bovine pulmonary artery smooth muscle cells by an O-hexanoyl low-molecular-weight heparin derivative.

Authors:  Hari G Garg; Charles A Hales; Lunyin Yu; Melissa Butler; Tasneem Islam; Jin Xie; Robert J Linhardt
Journal:  Carbohydr Res       Date:  2006-08-22       Impact factor: 2.104

Review 6.  Immobilization of heparin: approaches and applications.

Authors:  Saravanababu Murugesan; Jin Xie; Robert J Linhardt
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

Review 7.  Borrelia burgdorferi glycosaminoglycan-binding proteins: a potential target for new therapeutics against Lyme disease.

Authors:  Yi-Pin Lin; Lingyun Li; Fuming Zhang; Robert J Linhardt
Journal:  Microbiology       Date:  2017-11-08       Impact factor: 2.777

8.  Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides.

Authors:  Anna Alekseeva; Benito Casu; Giangiacomo Torri; Sabrina Pierro; Annamaria Naggi
Journal:  Anal Biochem       Date:  2012-11-29       Impact factor: 3.365

9.  Identification of Heparin Modifications and Polysaccharide Inhibitors of Plasmodium falciparum Merozoite Invasion That Have Potential for Novel Drug Development.

Authors:  Michelle J Boyle; Mark Skidmore; Benjamin Dickerman; Lynsay Cooper; Anthony Devlin; Edwin Yates; Paul Horrocks; Craig Freeman; Wengang Chai; James G Beeson
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

10.  Non-anticoagulant Heparin as a Pre-exposure Prophylaxis Prevents Lyme Disease Infection.

Authors:  Yi-Pin Lin; Yanlei Yu; Ashley L Marcinkiewicz; Patricia Lederman; Thomas M Hart; Fuming Zhang; Robert J Linhardt
Journal:  ACS Infect Dis       Date:  2020-01-30       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.